Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Affiliate Society Council Spotlights State Efforts for Advocacy

Christopher D. Adams, MD, FACP, FACR, and Joseph Cantrell, JD  |  June 19, 2019

Former Speaker of the U.S. House of Representatives Tip O’Neil once said, “All politics is local.” Rheumatologists and rheumatology professionals can put this knowledge to good use. Meet your state representatives, and offer to become a resource on patient care concerns for them. Contact the influencers at your state medical society, and offer the same. Join the ACR advocacy Google group to keep up with issues around the country. Spend a few minutes talking to motivated patients. They can join you at the Legislative Action Center to write letters to legislators about the issues of importance to rheumatology.

Remember: Advocacy is a team sport, and—now more than ever—we need rheumatologists and patients to get off the bench and on the playing field.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Christopher D. Adams, MD, FACP, FACR, is chief of rheumatology for the East Alabama Rheumatology Center in Auburn/Opelika. His experience includes military medical practice (including health delivery logistics), clinical faculty at several medical schools, conducting clinical research and serving as the governmental affairs and managed care liaison for the Alabama Society for the Rheumatic Diseases. Dr. Adams is also the chair of the ACR’s Affiliate Society Council.

Joseph Cantrell, JD, is the senior manager of state affairs for the ACR.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Affiliate Society Council (ASC)biosimilar legislationbiosimilar substitutionsMedical Association of the State of Alabama (MASA)pharmacy benefit managers (PBMs)state loan forgiveness billstep therapy legislation

Related Articles

    ACR’s Affiliate Society Council Reports Solid Gains in Advocacy Efforts

    June 7, 2018

    It’s May, and soon, most state legislatures will be adjourning for the remainder of the year. Joseph Cantrell, JD, senior manager of state affairs for the ACR, who tracks the progress of state and federal patient care legislation, reports that several states saw solid gains during 2018 state sessions, which typically run from January to…

    High Cost of Specialty Drugs Demands Action

    July 6, 2021

    Amid rising drug costs and the growing influence of pharmacy benefit managers on patient care decisions, physicians are increasingly called upon to advocate for affordable, evidence-based treatments for their patients.

    Rheumatologists Air Frustrations with Pharmacy Benefit Managers at Annual Meeting

    January 19, 2018

    SAN DIEGO—Pharmacy benefit managers (PBMs) and their impact on drug prices and access to high-cost medications by the patients rheumatologists treat was a major theme at the 2017 ACR/ARHP Annual Meeting Nov. 3–8. In one session, industry experts tried to clarify the role for prior authorizations and drug formulary policies and explored ways to constructively…

    Florida Law Puts Drug Pricing by Pharmacy Benefit Managers Under a Microscope Once Again

    August 8, 2022

    As of July 1, a Florida bill increases oversight of pharmacy benefit managers and offers some protection for pharmacies. However, the legislation has limited effects on patients and providers, highlighting the need for additional reform.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences